[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Adopts Innovative Technology for Faster Drug Discovery",
    "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) recently entered a licensing agreement with Telesis Bio Inc. to implement the Gibson SOLA™ platform, aiming to boost the company’s efficiency in the biotech sector. This development, along with robust clinical trial outcomes for its drug linvoseltamab, reflects the company's commitment to advancing its therapeutic capabilities. Despite these promising updates, the stock’s movement remained flat over the past month, aligning with broader market trends...",
    "url": "https://finnhub.io/api/news?id=d37c083ff35550fdc8c094f16f7f3dac012f9df2f5513626c928efa00fc75ea3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748452823,
      "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Adopts Innovative Technology for Faster Drug Discovery",
      "id": 134756068,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) recently entered a licensing agreement with Telesis Bio Inc. to implement the Gibson SOLA™ platform, aiming to boost the company’s efficiency in the biotech sector. This development, along with robust clinical trial outcomes for its drug linvoseltamab, reflects the company's commitment to advancing its therapeutic capabilities. Despite these promising updates, the stock’s movement remained flat over the past month, aligning with broader market trends...",
      "url": "https://finnhub.io/api/news?id=d37c083ff35550fdc8c094f16f7f3dac012f9df2f5513626c928efa00fc75ea3"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b436255be12bf32a87fa53b314f7154edc5db5a4adf1d479807cd5b1ce0492ea",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748450760,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "id": 134825923,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b436255be12bf32a87fa53b314f7154edc5db5a4adf1d479807cd5b1ce0492ea"
    }
  }
]